HeartSciences (HSCS) vs Massimo Group (MAMO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
HeartSciences (HSCS) has outperformed Massimo Group (MAMO) over the past year, losing 18.3% versus a loss of 67.3%. Massimo Group is the larger company by market cap ($38.9 million vs $15.4 million), about 2.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HSCS | MAMO |
|---|---|---|
| Share price | $3.18 | $0.935 |
| Market cap | $15.40M | $38.93M |
| 1-day change | +4.61% | -3.11% |
| YTD return | -1.62% | -75.75% |
| 1-year return | -18.28% | -67.29% |
| P/E ratio (TTM) | — | 9.35 |
| EPS (TTM) | $-3.21 | $0.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $5.25 | $5.59 |
| 52-week low | $1.63 | $0.66 |
| Distance from 52-week high | -39.43% | -83.27% |
| Analyst consensus | buy | — |
| Avg. price target upside | +277.36% | — |
| Average volume | 154.08K | 49.13K |
| Shares outstanding | 4.84M | 41.64M |
| Employees | 14 | 100 |
| Sector | Health Care | Consumer Discretionary |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Massimo Group is about 2.5 times larger than HeartSciences by market value ($38.93M vs $15.40M).
- HSCS has outperformed MAMO by 49.0 percentage points over the past year.
- The two companies sit in different sectors: HeartSciences in Health Care and Massimo Group in Consumer Discretionary.
About HeartSciences
HSCS stock →HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform.
Health Care · Industrial Specialties · 14 employees
About Massimo Group
MAMO stock →Massimo Group, through its subsidiaries, manufactures and sells utility terrain vehicles, all-terrain vehicles, and pontoon and tritoon boats to rural, agricultural, and commercial customers in the United States. It operates in two segments, Sales of UTVs, ATVs and e-bikes; and Sales of Pontoon Boats.
Consumer Discretionary · Industrial Specialties · 100 employees
HSCS vs MAMO FAQ
Which is bigger, HeartSciences or Massimo Group?
Massimo Group (MAMO) is larger, with a market capitalization of $38.93M compared with $15.40M for HeartSciences (HSCS).
Which stock has performed better over the past year, HSCS or MAMO?
HSCS returned -18.28% over the past 12 months, compared with -67.29% for MAMO (price return, excluding dividends). Past performance does not predict future results.
Are HeartSciences and Massimo Group in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.